Large-scale testing (Phase 3)Looking for participantsNCT07190196
What this trial is testing
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Who this might be right for
Immunoglobulin G4 Related Disease
Sanofi 124